孟凡凯 - Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

基本信息

浏览量：54

职业迁徙

个人简介

主持（过）国家自然科学基金项目、湖北省自然科学基金项目和武汉市应用基础研究项目等多项研究。发病论文数十篇。曾获湖北省及武汉市科技进步二等奖各一项。

研究兴趣

论文共 150 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Real-world cost-effectiveness study of autologous stem cell transplant plus CAR-T versus CAR-Ttherapy alone in Chinese patients with relapsed/refractory large B-cell lymphoma

Xiaojian Zhu, Zhengtao Zhou,Haitao Ruan, Ting Deng,Fankai Meng,Yang Cao,Liang Huang,Xiaoxi Zhou,Jianfeng Zhou

crossref（2024）

引用0浏览0引用

Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation

Haolong Lin, Ting Deng,Lijun Jiang,Fankai Meng,Yang Cao,Yicheng Zhang,Renying Ge,Xiaojian Zhu

CANCERS（2024）

引用0浏览0WOS引用

Efficacy of Programmed Cell Death 1 Inhibitor Maintenance after Chimeric Antigen Receptor T Cells in Patients with Relapsed/refractory B-cell Non-Hodgkin-lymphoma

Xiangke Xin,Xiaojian Zhu, Yang,Na Wang,Jue Wang,Jinhuan Xu,Jia Wei,Liang Huang,Miao Zheng,Yi Xiao,Chunrui Li,Yang Cao,Fankai Meng,Lijun Jiang,Yicheng Zhang

CELLULAR ONCOLOGYno. 4 (2024): 1425-1440

引用0浏览0WOS引用

Clinical Outcomes of Chimeric Antigen Receptor T-cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in 38 Patients with Refractory/relapsed Primary or Secondary Central Nervous System Lymphoma

Jiaying Wu, Wanying Liu,Yang Cao, Yang, Zhen Shang,Mi Zhou,Yicheng Zhang,Fankai Meng, Xiaojian Zhu,Yi Xiao

Cancer Immunology, Immunotherapyno. 1 (2024): 1-14

引用0浏览0WOS引用

Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment with Haploid Hematopoietic Stem Cell Transplantation Using Modified Post-transplantation Cyclophosphamide

Andie Fu,Yizhou Peng,Ping Cheng,Jiaying Wu,Xiaojian Zhu, Yang,Lifang Huang,Na Wang,Jue Wang,Jinhuan Xu,Yuling Wan,Yang Cao,Jia Wei,Yi Xiao,Fankai Meng,Hui Cheng,Yicheng Zhang,Donghua Zhang

TRANSPLANTATION AND CELLULAR THERAPYno. 5 (2024): 500-509

引用0浏览0WOS引用

Frontline Combination of Dasatinib and Low-Intensity Chemotherapy in Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yizhou Peng,Jinjin Huang,Jin Yin,Fankai Meng,Yang Cao,Liang Huang,Dengju Li,Yicheng Zhang,Donghua Zhang,Li Meng,Zhiqiang Han,Zhenya Hong

EXPERT REVIEW OF HEMATOLOGYno. 4-5 (2024): 173-180

引用0浏览0WOS引用

Prognostic Differences Between Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) and Carmustine, Etoposide, Cytarabine, Melphalan and Fludarabine (BEAMF) Regimens Before Autologous Stem Cell Transplantation Plus Chimeric Antigen Receptor T Therapy in Patients with Refractory/relapsed B-cell Non-Hodgkin-lymphoma

Xiangke Xin,Li Lin, Yang,Na Wang,Jue Wang,Jinhuan Xu,Jia Wei,Liang Huang,Miao Zheng,Yi Xiao,Fankai Meng,Yang Cao,Xiaojian Zhu,Yicheng Zhang

CYTOTHERAPYno. 5 (2024): 456-465

引用0浏览0WOS引用

Case Report: Acute HHV6B Encephalitis/myelitis Post CAR-T Cell Therapy in Patients with Relapsed/refractory Aggressive B-cell Lymphoma

Ningwen Li, Ruoxuan Zhang,Jue Wang,Xiaojian Zhu,Fankai Meng,Yang Cao,Gaoxiang Wang, Yang

FRONTIERS IN NEUROLOGY (2024)

引用0浏览0WOS引用

Efficacy and Safety of Chimeric Antigen Receptor T-cell Therapy Targeting CD19/CD22 in Refractory/relapsed Transformed Aggressive B-cell Lymphoma

Hao Xu,Qiuxia Lv,Liang Huang,Wenyue Cao,Jue Wang,Fankai Meng,Chunrui Li,Miao Zheng,Liting Chen,Ketao Mu,Jiali Cheng,Li Zhu,Jianfeng Zhou,Yicheng Zhang,Na Wang,Yang Cao

Cytotherapyno. 2 (2023): 185-191

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Fankai Meng(孟凡凯)

副主任医师

论文共 150 篇作者统计合作学者相似作者